Literature DB >> 2329015

Selective killing of tumor cells in vitro by an immunotoxin composed of ricin and monoclonal antibody against Ia antigen.

M Wu1, S L Tang, R J Zang, H Yu.   

Abstract

A monoclonal antibody (MAb-HB55) directed against a HLA class II antigen (Ia), was purified by DE-52 chromatography. The purified MAb contained less than 5% impure protein detected by SDS-PAGE. Ricin was conjugated with the MAb via a disulfide bond to construct an immunotoxin (ricin-HB55). The concentration causing fifty percent growth inhibition (IC50) was 2 x 10(-11)M for the Raji cells. In contrast, the IC50 for Molt-4 and K562 cells was 100 times higher than that for the Raji cells. B lymphocytes separated from peripheral blood lymphocytes by nylon wool were selectively killed by the conjugate, but T lymphocytes were not apparently affected. Our results demonstrate that the immunotoxin is selectively cytotoxic to Raji cells and B-cells, and may have potential for purging malignant cells from bone marrow of patients with B-cell leukemia and lymphoma.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2329015     DOI: 10.1016/0192-0561(90)90058-u

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  3 in total

1.  Annexin A2 Regulates Autophagy in Pseudomonas aeruginosa Infection through the Akt1-mTOR-ULK1/2 Signaling Pathway.

Authors:  Rongpeng Li; Shirui Tan; Min Yu; Michael C Jundt; Shuang Zhang; Min Wu
Journal:  J Immunol       Date:  2015-09-14       Impact factor: 5.422

Review 2.  Enhancement of immunotoxin activity using chemical and biological reagents.

Authors:  M Wu
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 3.  Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.

Authors:  Roger Gilabert-Oriol; Alexander Weng; Benedicta von Mallinckrodt; Matthias F Melzig; Hendrik Fuchs; Mayank Thakur
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.